Correction to: Cell Research https://doi.org/10.1038/s41422-024-00945-0, published online 15 March 2024
In the original publication of the paper, there were several mistakes in the text and figures.
First, the equal contribution statement was wrongly assigned number 24 instead of number 23. The correct statement should be “23 These authors contributed equally: Lin Fan, Junwei Liu, Wei Hu.”
In Fig. 3a, the cluster frequency annotation was incorrect and has been re-ordered to match the rows of the heatmap.
In Fig. 4g, a typo was corrected in the two y-axis: they should read ‘IL-2 concentration (pg/mL)’ and ‘IFN-γ concentration (pg/mL) respectively.
In Fig. 6a, the Y-Axis of the purple bar graph was corrected from “Frequency of PD-L1+CD45– cells” to ““Frequency of PD-L1+CD45+ cells”.
In the caption of Fig. 6, the description “d Diagram showing micro-peptide adhesion assay for examining the cell-cell adhesion frequency (Pa%) between CD64+ PBMCs and primary PD-1+ T cells bound with Nivolumab or not” was corrected to “d Diagram showing micro-pipette adhesion assay for examining the cell-cell adhesion frequency (Pa%) between CD64+ PBMCs and primary PD-1+ T cells bound with Nivolumab or not.”
Similarly, in the section “In-situ detection of CD64/anti-PD-1-mAb/PD-1 interaction on living primary cells”, the following sentence “We performed a micro-peptide adhesion assay to qualitatively determine the in-situ interaction of primary CD64+ cells and primary PD-1+ T cells treated with Nivolumab or not” was corrected to “We performed a micro-pipette adhesion assay to qualitatively determine the in-situ interaction of primary CD64+ cells and primary PD-1+ T cells treated with Nivolumab or not”.
Furthermore, the terms ‘Fc-binding’ and ‘non-Fc-binding’ have been corrected to ‘FcγR-binding’ and ‘non-FcγR-binding’, throughout the text, in Fig. 6 as well as in the Supplementary information, Figs. S11 and S12. Finally, the reference 53 was corrected from “Liora, V. et al. Rora regulates activated T helper cells during inflammation. bioRxiv. https://doi.org/10.1101/709998 (2020)” to “Haim-Vilmovsky, L. et al. Mapping Rora expression in resting and activated CD4+ T cells. PLoS ONE 16, e0251233 (2021)”.
We are sorry for these mistakes, and confirm that these corrections do not affect the results or the conclusion of this work. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fan, L., Liu, J., Hu, W. et al. Author Correction: Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Res 34, 815 (2024). https://doi.org/10.1038/s41422-024-01003-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41422-024-01003-5